Skip to main content
NCBI home page
Immunology logoLink to Immunology
. 1993 May;79(1):152–157.

Prevention of pristane-induced arthritis by the oral administration of type II collagen.

S J Thompson 1, H S Thompson 1, N Harper 1, M J Day 1, A J Coad 1, C J Elson 1, N A Staines 1
PMCID: PMC1422061  PMID: 8509136

Abstract

This is the first demonstration of a role for type II collagen in pristane-induced arthritis. Pretreatment with soluble type II collagen either lowers or raises the subsequent incidence and severity of pristane-induced arthritis. These effects are dependent upon both the dose and route of administration of the soluble type II collagen. Increasing doses of orally administered type II collagen lowered both the incidence and severity of pristane-induced arthritis. Conversely, increasing doses of intraperitoneally administered type II collagen increased both the incidence and severity of arthritis. This exacerbation of pristane-induced arthritis was accompanied by elevated B- and T-cell responses to type II collagen. These findings highlight the importance of the site at which antigen is encountered in influencing subsequent immune responses and extend the observations of the use of orally administered antigens to ameliorate experimental autoimmunity.

Full text

PDF
152

Images in this article

153Figure 1
on p.153

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bedwell A. E., Elson C. J., Hinton C. E. Immunological involvement in the pathogenesis of pristane-induced arthritis. Scand J Immunol. 1987 Apr;25(4):393–398. doi: 10.1111/j.1365-3083.1987.tb02205.x. [DOI] [PubMed] [Google Scholar]
  2. Bitar D. M., Whitacre C. C. Suppression of experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein. Cell Immunol. 1988 Apr 1;112(2):364–370. doi: 10.1016/0008-8749(88)90305-x. [DOI] [PubMed] [Google Scholar]
  3. Brod S. A., al-Sabbagh A., Sobel R. A., Hafler D. A., Weiner H. L. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin antigens: IV. Suppression of chronic relapsing disease in the Lewis rat and strain 13 guinea pig. Ann Neurol. 1991 Jun;29(6):615–622. doi: 10.1002/ana.410290608. [DOI] [PubMed] [Google Scholar]
  4. Chapdelaine J. M., Whalen J. D., Wooley P. H. Pristane induced arthritis. II. Genetic regulation in F1 hybrid mice and cellular immune abnormalities following pristane injection. Autoimmunity. 1991;8(3):215–220. doi: 10.3109/08916939108997109. [DOI] [PubMed] [Google Scholar]
  5. Engleman E. G., Benike C. J., Grumet F. C., Evans R. L. Activation of human T lymphocyte subsets: helper and suppressor/cytotoxic T cells recognize and respond to distinct histocompatibility antigens. J Immunol. 1981 Nov;127(5):2124–2129. [PubMed] [Google Scholar]
  6. Higgins P. J., Weiner H. L. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein and its fragments. J Immunol. 1988 Jan 15;140(2):440–445. [PubMed] [Google Scholar]
  7. Hitsumoto Y., Thompson S. J., Zhang Y. W., Rook G. A., Elson C. J. Relationship between interleukin 6, agalactosyl IgG and pristane-induced arthritis. Autoimmunity. 1992;11(4):247–254. doi: 10.3109/08916939209035162. [DOI] [PubMed] [Google Scholar]
  8. Hopkins S. J., Freemont A. J., Jayson M. I. Pristane-induced arthritis in Balb/c mice. I. Clinical and histological features of the arthropathy. Rheumatol Int. 1984;5(1):21–28. doi: 10.1007/BF00541361. [DOI] [PubMed] [Google Scholar]
  9. Nagler-Anderson C., Bober L. A., Robinson M. E., Siskind G. W., Thorbecke G. J. Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen. Proc Natl Acad Sci U S A. 1986 Oct;83(19):7443–7446. doi: 10.1073/pnas.83.19.7443. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Nussenblatt R. B., Caspi R. R., Mahdi R., Chan C. C., Roberge F., Lider O., Weiner H. L. Inhibition of S-antigen induced experimental autoimmune uveoretinitis by oral induction of tolerance with S-antigen. J Immunol. 1990 Mar 1;144(5):1689–1695. [PubMed] [Google Scholar]
  11. Potter M., Wax J. S. Genetics of susceptibility to pristane-induced plasmacytomas in BALB/cAn: reduced susceptibility in BALB/cJ with a brief description of pristane-induced arthritis. J Immunol. 1981 Oct;127(4):1591–1595. [PubMed] [Google Scholar]
  12. Rook G., Thompson S., Buckley M., Elson C., Brealey R., Lambert C., White T., Rademacher T. The role of oil and agalactosyl IgG in the induction of arthritis in rodent models. Eur J Immunol. 1991 Apr;21(4):1027–1032. doi: 10.1002/eji.1830210425. [DOI] [PubMed] [Google Scholar]
  13. Staines N. A., Ekong T. A., Thompson H. S., Isaacs A. B., Loryman B., Major P. J., Hobbs S. M., Devey M. E. Low affinity antibodies against collagen type II are associated with pathology in collagen-induced arthritis in mice. J Autoimmun. 1990 Dec;3(6):643–657. doi: 10.1016/s0896-8411(05)80032-0. [DOI] [PubMed] [Google Scholar]
  14. Staines N. A., Hardingham T., Smith M., Henderson B. Collagen-induced arthritis in the rat: modification of immune and arthritic responses by free collagen and immune anti-collagen antiserum. Immunology. 1981 Dec;44(4):737–744. [PMC free article] [PubMed] [Google Scholar]
  15. Taurog J. D., Kerwar S. S., McReynolds R. A., Sandberg G. P., Leary S. L., Mahowald M. L. Synergy between adjuvant arthritis and collagen-induced arthritis in rats. J Exp Med. 1985 Sep 1;162(3):962–978. doi: 10.1084/jem.162.3.962. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Thompson H. S., Staines N. A. Could specific oral tolerance be a therapy for autoimmune disease? Immunol Today. 1990 Nov;11(11):396–399. doi: 10.1016/0167-5699(90)90158-6. [DOI] [PubMed] [Google Scholar]
  17. Thompson H. S., Staines N. A. Gastric administration of type II collagen delays the onset and severity of collagen-induced arthritis in rats. Clin Exp Immunol. 1986 Jun;64(3):581–586. [PMC free article] [PubMed] [Google Scholar]
  18. Thompson S. J., Hitsumoto Y., Zhang Y. W., Rook G. A., Elson C. J. Agalactosyl IgG in pristane-induced arthritis. Pregnancy affects the incidence and severity of arthritis and the glycosylation status of IgG. Clin Exp Immunol. 1992 Sep;89(3):434–438. doi: 10.1111/j.1365-2249.1992.tb06976.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Thompson S. J., Rook G. A., Brealey R. J., Van der Zee R., Elson C. J. Autoimmune reactions to heat-shock proteins in pristane-induced arthritis. Eur J Immunol. 1990 Nov;20(11):2479–2484. doi: 10.1002/eji.1830201118. [DOI] [PubMed] [Google Scholar]
  20. Zhang Z. J., Davidson L., Eisenbarth G., Weiner H. L. Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin. Proc Natl Acad Sci U S A. 1991 Nov 15;88(22):10252–10256. doi: 10.1073/pnas.88.22.10252. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Zhang Z. Y., Lee C. S., Lider O., Weiner H. L. Suppression of adjuvant arthritis in Lewis rats by oral administration of type II collagen. J Immunol. 1990 Oct 15;145(8):2489–2493. [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES